Pennsylvania SB865 amends urine drug screening requirements and mandates medetomidine awareness education.

Pennsylvania SB865 amends Title 35 of the Pennsylvania Consolidated Statutes to require urine drug screenings in emergency departments to test for fentanyl, medetomidine, and xylazine. The Department of Drug and Alcohol Programs must create educational materials about the dangers of medetomidine use, in partnership with health care providers and community-based health centers. The bill also mandates reporting of test results if fentanyl, medetomidine, or xylazine are detected.

Pennsylvania SB865 amends urine drug screening requirements and mandates medetomidine awareness education.

Pennsylvania SB865 amends Title 35 of the Pennsylvania Consolidated Statutes to require urine drug screenings in emergency departments to test for fentanyl, medetomidine, and xylazine. The Department of Drug and Alcohol Programs must create educational materials about the dangers of medetomidine use, in partnership with health care providers and community-based health centers. The bill also mandates reporting of test results if fentanyl, medetomidine, or xylazine are detected.